BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 169 filers reported holding BRIDGEBIO PHARMA INC in Q4 2020. The put-call ratio across all filers is 0.33 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,994,653 | +150.7% | 75,641 | +63.5% | 0.00% | +200.0% |
Q2 2023 | $795,724 | -65.0% | 46,263 | -66.2% | 0.00% | -66.7% |
Q1 2023 | $2,270,514 | +616.6% | 136,943 | +229.4% | 0.00% | – |
Q4 2022 | $316,824 | -23.3% | 41,578 | 0.0% | 0.00% | -100.0% |
Q3 2022 | $413,285 | +9.3% | 41,578 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $378,000 | -10.4% | 41,578 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $422,000 | -39.2% | 41,578 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $694,000 | -64.8% | 41,578 | -1.1% | 0.00% | -75.0% |
Q3 2021 | $1,971,000 | -23.7% | 42,060 | -0.8% | 0.00% | -20.0% |
Q2 2021 | $2,583,000 | +1.6% | 42,379 | +2.7% | 0.01% | 0.0% |
Q1 2021 | $2,543,000 | +12.9% | 41,278 | +30.3% | 0.01% | 0.0% |
Q4 2020 | $2,253,000 | +139.7% | 31,688 | +26.5% | 0.01% | +150.0% |
Q3 2020 | $940,000 | +12.0% | 25,042 | -2.6% | 0.00% | 0.0% |
Q2 2020 | $839,000 | -21.9% | 25,717 | -30.6% | 0.00% | -33.3% |
Q1 2020 | $1,074,000 | +182.6% | 37,038 | +241.7% | 0.00% | +200.0% |
Q4 2019 | $380,000 | – | 10,839 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital Management LP | 6,068,125 | $160,016,456 | 65.94% |
Kohlberg Kravis Roberts & Co. L.P. | 31,060,971 | $819,077,805 | 28.79% |
Cormorant Asset Management, LP | 4,662,530 | $122,950,916 | 7.17% |
Frazier Life Sciences Management, L.P. | 2,725,949 | $71,883,275 | 4.77% |
Octagon Capital Advisors LP | 971,639 | $25,622,120 | 3.94% |
M28 Capital Management LP | 121,200 | $3,196,044 | 3.66% |
VIKING GLOBAL INVESTORS LP | 25,120,991 | $662,440,533 | 2.69% |
BOONE CAPITAL MANAGEMENT LLC | 313,381 | $8,263,857 | 2.61% |
Fernwood Investment Management, LLC | 235,620 | $6,213,299 | 2.23% |
SOUTHPORT MANAGEMENT, L.L.C. | 15,000 | $395,550 | 2.15% |